Hack Andrew A. F.
Insider CIK 1657434 · DVAX Director · MRSN Director · AVIR Director · ALNA Director · EDIT Chief Financial Officer · BLSA Chief Financial Officer, Director, 10% owner · NUVL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 734 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 400 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,088 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,460 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,200 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 439 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,002 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 118 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 368 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 578 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 346,545 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 61,500 | — | $0 | 61,500 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-12-11 | 2024-12-13 | 1,250,000 | $88.00 | $110.00M | 1,447,267 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 3,789 | — | $0 | 3,789 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2024-06-12 | 2024-06-14 | 2,499 | — | $0 | 2,499 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-03-27 | 2024-03-29 | 88,205 | $76.88 | $6.78M | 3,489,062 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-03-27 | 2024-03-29 | 791,795 | $72.31 | $57.25M | 2,697,267 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2023-08-08 | 2023-08-10 | 1,500,000 | $14.39 | $21.59M | 915,000 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2023-06-14 | 2023-06-16 | 500,000 | $12.68 | $6.34M | 2,415,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,355 | — | $0 | 18,355 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-12 | 14,467 | — | $0 | 14,467 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2023-05-26 | 2023-05-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2023-05-26 | 2023-05-31 | 5,357 | — | $0 | 10,714 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2023-05-18 | 2023-05-19 | 1,000,000 | $10.55 | $10.55M | 2,915,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-12-06 | 2022-12-08 | 1,500,000 | $11.60 | $17.40M | 3,915,000 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy | 2022-11-03 | 2022-11-03 | 149,253 | $33.50 | $5.00M | 3,577,267 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-08-15 | 2022-08-17 | 3,000,000 | $14.68 | $44.04M | 5,415,000 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-06-02 | 2022-06-02 | 14,760 | $3.20 | $47.2K | 8,663,673 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-31 | 2022-06-02 | 80,759 | $3.28 | $264.9K | 8,648,913 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 5,357 | — | $0 | 5,357 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-26 | 2022-05-26 | 75,000 | $3.19 | $239.3K | 8,568,154 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-25 | 2022-05-26 | 90,155 | $3.18 | $286.7K | 8,493,154 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-24 | 2022-05-26 | 100,000 | $3.29 | $329.0K | 8,402,999 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-23 | 2022-05-23 | 15,599 | $3.35 | $52.3K | 8,302,999 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-20 | 2022-05-23 | 100,000 | $3.46 | $346.0K | 8,287,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-19 | 2022-05-23 | 100,000 | $3.49 | $349.0K | 8,187,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-18 | 2022-05-18 | 211,268 | $3.35 | $707.7K | 8,087,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-17 | 2022-05-18 | 3,440 | $3.18 | $10.9K | 7,876,132 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-05-16 | 2022-05-18 | 135,292 | $3.10 | $419.4K | 7,872,692 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-04-13 | 2022-04-14 | 617,284 | $4.05 | $2.50M | 7,737,400 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-13 | 598,086 | $4.18 | $2.50M | 7,120,116 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2022-02-07 | 2022-02-08 | 1,136,363 | $4.42 | $5.02M | 6,522,030 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 10,995 | — | $0 | 10,995 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2021-12-30 | 2022-01-04 | 815,000 | $6.15 | $5.01M | 5,385,667 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2021-12-29 | 2022-01-03 | 875,000 | $5.75 | $5.03M | 4,570,667 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | C Conversion deriv | 2021-08-27 | 2021-08-27 | 1,891 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | C Conversion | 2021-08-27 | 2021-08-27 | 1,891,000 | — | $0 | 10,415,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2021-08-27 | 2021-08-27 | 2,000,000 | $16.22 | $32.44M | 8,415,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | C Conversion deriv | 2021-08-09 | 2021-08-11 | 2,249 | — | $0 | 1,891 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | C Conversion | 2021-08-09 | 2021-08-11 | 2,249,000 | — | $0 | 10,774,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2021-08-09 | 2021-08-11 | 2,250,000 | $10.80 | $24.30M | 8,524,000 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 14,494,154 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy | 2021-08-02 | 2021-08-04 | 735,000 | $17.00 | $12.49M | 3,428,014 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 2,693,014 | — | $0 | 2,693,014 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2021-07-28 | 2021-07-30 | 43,000 | — | $0 | 43,000 | SEC↗ |
| MRSN] Mersana Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 25,050 | — | $0 | 25,050 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale deriv | 2021-06-10 | 2021-06-11 | 2,916,250 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-05-28 | 2021-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRSN] Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,971 | — | $0 | 2,971 | SEC↗ |
| MRSN] Mersana Therapeutics, Inc. | P Buy | 2021-01-12 | 2021-01-12 | 75,000 | $18.16 | $1.36M | 3,695,667 | SEC↗ |
| MRSN] Mersana Therapeutics, Inc. | P Buy | 2021-01-11 | 2021-01-12 | 75,000 | $18.52 | $1.39M | 3,620,667 | SEC↗ |
| MRSN] Mersana Therapeutics, Inc. | P Buy | 2021-01-08 | 2021-01-12 | 100,000 | $18.39 | $1.84M | 3,545,667 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | A Award deriv | 2020-11-17 | 2020-11-18 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 3,383,190 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 1,982,469 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-03 | 5,365,659 | — | $0 | 5,365,659 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2020-11-03 | 2020-11-03 | 250,000 | $24.00 | $6.00M | 5,615,659 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2020-10-29 | 2020-10-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BLSA BCLS Acquisition Corp. | A Award | 2020-10-26 | 2020-10-26 | 487,500 | $10.00 | $4.88M | 487,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-29 | 9,200 | — | $0 | 9,200 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2020-05-28 | 2020-05-29 | 18,750 | — | $0 | 18,750 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | P Buy | 2020-05-27 | 2020-05-28 | 1,000,000 | $5.00 | $5.00M | 8,525,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2020-04-07 | 2020-04-09 | 2,800,000 | $5.59 | $15.65M | 2,800,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2020-04-07 | 2020-04-09 | 645,667 | $7.74 | $5.00M | 3,445,667 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2020-03-11 | 2020-03-12 | 1 | — | $0 | 1 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2019-08-12 | 2019-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | A Award deriv | 2019-06-05 | 2019-06-07 | 14,000 | — | $0 | 14,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2019-02-04 | 2019-02-06 | 6,895 | — | $0 | 9,618 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2019-02-04 | 2019-02-06 | 6,895 | $21.39 | $147.5K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2019-02-04 | 2019-02-06 | 6,895 | $6.48 | $44.7K | 6,895 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2019-01-04 | 2019-01-08 | 7,000 | — | $0 | 16,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2019-01-04 | 2019-01-08 | 7,000 | $22.48 | $157.4K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2019-01-04 | 2019-01-08 | 7,000 | $6.48 | $45.4K | 7,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-11-23 | 2019-01-08 | 5,284 | — | $0 | 119,143 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-11-23 | 2019-01-08 | 5,284 | $3.23 | $17.1K | 5,284 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-11-23 | 2018-11-27 | 5,284 | — | $0 | 12,229 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-11-23 | 2018-11-27 | 100 | $28.61 | $2.9K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-11-23 | 2018-11-27 | 5,184 | $28.14 | $145.9K | 100 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-11-23 | 2018-11-27 | 5,284 | $6.48 | $34.2K | 5,284 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-10-26 | 2019-01-08 | 6,000 | — | $0 | 124,427 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-10-26 | 2019-01-08 | 6,000 | $3.23 | $19.4K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-10-26 | 2018-10-30 | 6,000 | — | $0 | 17,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-10-26 | 2018-10-30 | 6,000 | $25.70 | $154.2K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-10-26 | 2018-10-30 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-09-28 | 2018-10-02 | 8,000 | — | $0 | 23,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-09-28 | 2018-10-02 | 8,000 | $6.48 | $51.8K | 8,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-09-28 | 2018-10-02 | 8,000 | $32.08 | $256.6K | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-09-20 | 2018-09-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-08-31 | 2018-09-05 | 10,000 | — | $0 | 31,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-08-31 | 2018-09-05 | 10,000 | $32.23 | $322.3K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-08-31 | 2018-09-05 | 10,000 | $6.48 | $64.8K | 10,000 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | A Award deriv | 2018-06-08 | 2018-06-12 | 20,364 | — | $0 | 20,364 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-06-04 | 2018-06-05 | 3,000 | — | $0 | 67,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-06-04 | 2018-06-05 | 3,000 | $24.60 | $73.8K | 3,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-06-04 | 2018-06-05 | 3,000 | $37.10 | $111.3K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-06-01 | 2018-06-05 | 7,000 | — | $0 | 41,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-06-01 | 2018-06-05 | 2,000 | $39.86 | $79.7K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-06-01 | 2018-06-05 | 5,000 | $6.48 | $32.4K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-06-01 | 2018-06-05 | 5,000 | $39.05 | $195.3K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-06-01 | 2018-06-05 | 2,000 | $6.48 | $13.0K | 2,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-03-20 | 2018-03-20 | 22,000 | — | $0 | 70,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-03-20 | 2018-03-20 | 6,000 | — | $0 | 48,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-03-20 | 2018-03-20 | 22,000 | $24.60 | $541.2K | 22,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-03-20 | 2018-03-20 | 1,000 | $38.39 | $38.4K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-03-20 | 2018-03-20 | 1,000 | $6.48 | $6.5K | 1,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-03-20 | 2018-03-20 | 5,000 | $37.51 | $187.6K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-03-20 | 2018-03-20 | 5,000 | $6.48 | $32.4K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-03-20 | 2018-03-20 | 22,000 | $37.91 | $834.0K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-03-19 | 2018-03-20 | 6,000 | — | $0 | 54,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-03-19 | 2018-03-20 | 6,000 | $37.65 | $225.9K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-03-19 | 2018-03-20 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-03-16 | 2018-03-20 | 6,000 | — | $0 | 60,513 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-03-16 | 2018-03-20 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-03-16 | 2018-03-20 | 6,000 | $39.43 | $236.6K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-02-16 | 2018-02-16 | 6,000 | — | $0 | 63,662 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-02-16 | 2018-02-16 | 6,000 | $35.32 | $211.9K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-02-16 | 2018-02-16 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-02-15 | 2018-02-16 | 6,000 | — | $0 | 69,662 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-02-15 | 2018-02-16 | 6,000 | $34.61 | $207.7K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-02-15 | 2018-02-16 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2018-02-14 | 2018-02-16 | 6,000 | — | $0 | 75,662 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2018-02-14 | 2018-02-16 | 6,000 | $32.71 | $196.3K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2018-02-14 | 2018-02-16 | 6,000 | $6.48 | $38.9K | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2018-02-07 | 2018-02-09 | 95,000 | — | $0 | 95,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-12-19 | 2017-12-19 | 4,649 | — | $0 | 130,427 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-12-19 | 2017-12-19 | 4,649 | $3.23 | $15.0K | 4,649 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-12-19 | 2017-12-19 | 4,649 | $25.06 | $116.5K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-19 | 5,000 | — | $0 | 135,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-12-18 | 2017-12-19 | 5,000 | $24.68 | $123.4K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-12-18 | 2017-12-19 | 5,000 | $3.23 | $16.1K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-19 | 5,000 | — | $0 | 140,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-12-15 | 2017-12-19 | 5,000 | $24.31 | $121.5K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-12-15 | 2017-12-19 | 5,000 | $3.23 | $16.1K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-11-20 | 2017-11-21 | 5,000 | — | $0 | 145,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-11-20 | 2017-11-21 | 5,000 | $3.23 | $16.1K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-11-20 | 2017-11-21 | 5,000 | $25.35 | $126.8K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-11-17 | 2017-11-21 | 5,000 | — | $0 | 150,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-11-17 | 2017-11-21 | 5,000 | $24.81 | $124.0K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-11-17 | 2017-11-21 | 5,000 | $3.23 | $16.1K | 5,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-03-01 | 2017-03-03 | 92,500 | — | $0 | 92,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-02-15 | 2017-02-16 | 3,000 | — | $0 | 155,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-02-15 | 2017-02-16 | 3,000 | $3.23 | $9.7K | 3,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-02-15 | 2017-02-16 | 3,000 | $19.20 | $57.6K | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise deriv | 2017-01-11 | 2017-01-13 | 15,000 | — | $0 | 158,076 | SEC↗ |
| EDIT Editas Medicine, Inc. | M Exercise | 2017-01-11 | 2017-01-13 | 15,000 | $3.23 | $48.5K | 15,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2017-01-11 | 2017-01-13 | 15,000 | $19.20 | $288.0K | 0 | SEC↗ |